Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Asthma and allergy

  • Association of genetic risk and lifestyle with incident adult-onset asthma in the UK Biobank cohort
    Huaying Liang, Danrong Jing, Yiqun Zhu, Dianwu Li, Xin Zhou, Wei Tu, Hong Liu, Pinhua Pan, Yan Zhang
    ERJ Open Research Mar 2023, 9 (2) 00499-2022; DOI: 10.1183/23120541.00499-2022
  • Prevalence and management of severe asthma in the Nordic countries: findings from the NORDSTAR cohort
    Susanne Hansen, Anna von Bülow, Patrik Sandin, Olivia Ernstsson, Christer Janson, Lauri Lehtimäki, Hannu Kankaanranta, Charlotte Ulrik, Bernt Bøgvald Aarli, Hanna Fues Wahl, Kirk Geale, Sheila Tuyet Tang, Maija Wolf, Tom Larsen, Alan Altraja, Helena Backman, Maritta Kilpeläinen, Arja Viinanen, Dora Ludviksdottir, Paula Kauppi, Asger Sverrild, Sverre Lehmann, Vibeke Backer, Valentyna Yasinska, Tina Skjold, Jussi Karjalainen, Apostolos Bossios, Celeste Porsbjerg
    ERJ Open Research Mar 2023, 9 (2) 00687-2022; DOI: 10.1183/23120541.00687-2022
  • Evaluation of real-world mepolizumab use in severe asthma across Europe: the SHARP experience with privacy-preserving federated analysis
    Johannes A. Kroes, Rafael Alfonso-Cristancho, Aruna T. Bansal, Emmanuelle Berret, Kristina Bieksiene, Arnaud Bourdin, Luisa Brussino, Diogo Canhoto, Cristina Cardini, Gulfem Celik, Zsuzsanna Csoma, Barbro Dahlén, Ebru Damadoglu, Katrien Eger, Lisa Gauquelin, Bilun Gemicioglu, Ozlem Goksel, Sophie Graff, Enrico Heffler, Hendrik B. Hofstee, Peter Howarth, Rupert W. Jakes, Fabienne Jaun, Virginija Kalinauskaite-Zukauske, Peter Kopač, Namhee Kwon, Claudia C. Loureiro, Victor Lozoya García, Matthew Masoli, Mariana Paula Rezelj, Luis Pérez De Llano, Sanja Popović-Grle, David Ramos-Barbón, Ana Sà Sousa, Konstantinos Samitas, Florence Schleich, Concetta Sirena, Sabina Skrgat, Eleftherios Zervas, George Zichnalis, Elisabeth H. Bel, Jacob K. Sont, Simone Hashimoto, Anneke Ten Brinke
    ERJ Open Research Mar 2023, 9 (2) 00745-2022; DOI: 10.1183/23120541.00745-2022
  • Functional imaging in asthma and COPD: design of the NOVELTY ADPro substudy
    Helen Marshall, Jim M. Wild, Laurie J. Smith, Latife Hardaker, Titti Fihn-Wikander, Hana Müllerová, Rod Hughes
    ERJ Open Research Mar 2023, 9 (2) 00344-2022; DOI: 10.1183/23120541.00344-2022
  • Airway wall splice quantitative trait locus analysis reveals novel downstream mechanisms for known asthma single-nucleotide polymorphisms
    Tessa M. Kole, Simon D. Pouwels, Rene Bults, Marlies E. Ketelaar, Victor Guryev, Lisanne Koll, Huib A.M. Kerstjens, Martijn C. Nawijn, Alen Faiz, Maarten van den Berge
    ERJ Open Research Mar 2023, 9 (2) 00413-2022; DOI: 10.1183/23120541.00413-2022
  • Early prediction of bronchopulmonary dysplasia: can noninvasive monitoring methods be essential?
    Xuewei Cui, Jianhua Fu
    ERJ Open Research Mar 2023, 9 (2) 00621-2022; DOI: 10.1183/23120541.00621-2022
  • Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy in patients with asthma: REACH study design
    Akio Niimi, Yoshihiro Kanemitsu, Tomoko Tajiri, Kazuya Sumi, Toshiaki Mikami, Norihiko Kondo
    ERJ Open Research Mar 2023, 9 (2) 00452-2022; DOI: 10.1183/23120541.00452-2022
  • Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population
    Laurits Frøssing, Ditte K. Klein, Morten Hvidtfeldt, Nicolai Obling, Gunilla Telg, Jonas S. Erjefält, Uffe Bodtger, Celeste Porsbjerg
    ERJ Open Research Mar 2023, 9 (2) 00483-2022; DOI: 10.1183/23120541.00483-2022
  • The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma
    Elisa Franceschi, Nora Drick, Jan Fuge, Pierachille Santus, Bettina Fischer, Moritz Kayser, Tobias Welte, Hendrik Suhling
    ERJ Open Research Mar 2023, 9 (2) 00341-2022; DOI: 10.1183/23120541.00341-2022
  • An inverse relationship between asthma prevalence and medication dispensation trend: a 12-year spatial analysis of electronic health record data in Alberta, Canada
    Subhabrata Moitra, Andrew Fong, Mohit Bhutani
    ERJ Open Research Mar 2023, 9 (2) 00489-2022; DOI: 10.1183/23120541.00489-2022

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 26
  • Acute lung injury and critical care (49)
  • Asthma and allergy (252)
  • CF and non-CF bronchiectasis (148)
  • COPD and smoking (362)
  • Epidemiology, occupational and environmental lung disease (63)
  • Genetics (30)
  • Interstitial and orphan lung disease (191)
  • Lung biology and experimental studies (93)
  • Lung cancer (82)
  • Lung imaging (63)
  • Lung structure and function (120)
  • Mechanisms of lung disease (5)
  • Paediatric pulmonology (116)
  • Pulmonary pharmacology and therapeutics (146)
  • Pulmonary vascular disease (97)
  • Respiratory clinical practice (98)
  • Respiratory infections and tuberculosis (380)
  • Sleep medicine (63)
  • Most Read
  • Twitter
Loading
  • Outcomes of community-acquired pneumonia using the Pneumonia Severity Index versus the CURB-65 in routine practice of emergency departments
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
  • Prevalence, treatment and determinants of obstructive sleep apnoea and its symptoms in a population-based French cohort
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society